Suchergebnisse - "Vinks, Alexander A"

PubPharm (13)

1

A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma : a Neurofibromatosis Clinical Trials Consortium study

enthalten in: Neuro-oncology | 2020

von Ullrich, N. | Prabhu, S. | Reddy, A. | +17

CommentIn: Neuro Oncol. 2020 Oct 14;22(10):1415-1416. - PMID 32974639

2

Significant effect of infection and food intake on sirolimus pharmacokinetics and exposure in pediatric patients with acute lymphoblastic leukemia

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2019

von Mizuno, T. | O'Brien, M. | Vinks, A.

3

Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies

enthalten in: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences | 2017

von Mizuno, T. | Emoto, C. | Fukuda, T. | +3

4

Developmental pharmacokinetics of sirolimus : Implications for precision dosing in neonates and infants with complicated vascular anomalies

enthalten in: Pediatric blood & cancer | 2017

von Mizuno, T. | Fukuda, T. | Emoto, C. | +4

5

Population pharmacokinetics of temsirolimus and sirolimus in children with recurrent solid tumours : a report from the Children's Oncology Group

enthalten in: British journal of clinical pharmacology | 2017

von Mizuno, T. | Fukuda, T. | Christians, U. | +3

6

Risk Assessment of Drug-Drug Interactions of Calcineurin Inhibitors Affecting Sirolimus Pharmacokinetics in Renal Transplant Patients

enthalten in: Therapeutic drug monitoring | 2016

von Emoto, C. | Vinks, A. | Fukuda, T.

7

Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies

enthalten in: Pediatrics | 2016

von Adams, D. | Trenor, C. | Hammill, A. | +21

8

The impact of CYP3A5*3 polymorphism on sirolimus pharmacokinetics : insights from predictions with a physiologically-based pharmacokinetic model

enthalten in: British journal of clinical pharmacology | 2015

von Emoto, C. | Fukuda, T. | Venkatasubramanian, R. | +1

9

Age-dependent changes in sirolimus metabolite formation in patients with neurofibromatosis type 1

enthalten in: Therapeutic drug monitoring | 2015

von Emoto, C. | Fukuda, T. | Mizuno, T. | +8

10

A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors : A Children's Oncology Group Phase I Consortium Report

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2015

von Fouladi, M. | Perentesis, J. | Wagner, L. | +11